COVID-19 – Doctor TV Channel

Nirmatrelvir-Ritonavir Fails to Improve Long-COVID

June 12, 2024

According to Peter A. McCullough, MD, MPH, paxlovid, a dual-action antiviral medication from Pfizer that combines ritonavir and nirmatrelvir, produced variable outcomes in acute COVID-19 patients. Th...

WHO Adopts Pandemic Censorship Rules

June 8, 2024

The World Health Organization (WHO) has formally accepted social control guidelines, the most concerning of which is the censorship of critics. Western governments initially developed these guidelin...

Latest Medical News from Doctor TV

Children less likely to have type 1 diabetes if mother has condition than if father is affected, study finds

New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD; Madrid, 9–13 September) shows that a child is almost twice as likely to develop type 1 diabetes (T1D) if their father has the condition, than if their mother has the condition. [...]

Boar's head recalls liverwurst tied to listeria outbreak

Boar's Head announced Friday that it was recalling all of its liverwurst products because they could be tainted with dangerous Listeria monocytogenes bacteria. [...]

Prostate cancer outcomes comparable for transgender women, cisgender men

Most prostate cancer outcomes do not differ significantly between transgender women (TGW) and cisgender (CG) men, including prostate cancer-specific mortality, according to a study published online July 21 in Cancer. [...]

New study shows 'dancing molecules' can regenerate cartilage in 3 days

In November 2021, Northwestern University researchers introduced an injectable new therapy, which harnessed fast-moving "dancing molecules," to repair tissues and reverse paralysis after severe spinal cord injuries. [...]

Chinese medicinal fungus shows promise in treating idiopathic pulmonary fibrosis

A study from China has reported that Cordyceps sinensis (CS), a traditional Chinese medicinal fungus, can ameliorate idiopathic pulmonary fibrosis (IPF) in mice by inhibiting mitochondrion-mediated oxidative stress. [...]

Combination drug strategy produces promising results by hyperactivating oncogenic signaling

A combination of two drugs was capable of suppressing tumors in a non-conventional manner. Instead of inhibiting tumor cell division, as the most widely used medications do, the strategy consisted of hyperactivating oncogenic signaling by these cells to the point where they became stressed. The other drug then attacked the stressed cells. The approach will be tested in colorectal cancer patients in the Netherlands later this year. [...]

Investigating the effect of alemtuzumab in allogeneic hematopoietic cell transplantation

Allogeneic hematopoietic cell transplantation (HCT) is a commonly used curative therapy for individuals with inborn errors of immunity (IEI). HCT involves introducing stem cells from a compatible donor with the aim of replacing the affected cells in the recipient's body. Reduced-toxicity conditioning (RTC) is an approach for reducing drug-related toxicities post HCT in patients with IEIs. [...]

Supporting school re-entry of children with special health care needs post extended hospitalizations

Children with special health care needs (CSHCN) often face significant disruptions in their education due to extended hospitalizations. A recent study published online in Disability and Rehabilitation on July 1, 2024, by a multidisciplinary team of Kessler Foundation and Children Specialized Hospital researchers, highlights critical areas needing attention to ensure smoother school re-entries for CSHCN, ensuring they receive the necessary educational support post-hospitalization. [...]

Study finds increased substance use with direct, indirect exposure to mass terrorism

For adults, increased substance use (ISU) is seen in populations with direct, indirect, and media exposure to mass terrorism, according to a study published online July 24 in JAMA Network Open. [...]

Study uncovers key immune cells for combating aggressive Merkel cell carcinoma

Merkel cell carcinoma is a rare but highly aggressive form of skin cancer known for its rapid growth and tendency to metastasize. Despite the promise of immune checkpoint blockade therapy, which can boost the body's immune response against cancer cells, nearly half of patients do not respond to this treatment. A new study published today in Cancer Discovery is providing insights into why some Merkel cell carcinoma patients respond to this type of immunotherapy while others do not. [...]